"Working together, we will greatly accelerate translational research that could lead to the development of vaccines to prevent cancer in the future." GSK and Oxford University are already ...

but to actually vaccinate against that pre-cancer stage.” University of Oxford professor Sarah Blagden, who is director of the partnership, said the research was aimed at finding ways to stop ...

Pharmaceutical company GSK and Oxford University are teaming up to devise a groundbreaking cancer vaccine poised to stop the disease from developing in the first place. The ambition lies in ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...

The University of Oxford or Oxford University is the oldest English-speaking institution of higher learning world-wide. Oxford University traces its roots to the 12th Century, but traces of it go ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...

Oxford University has world-leading expertise in the study of pre-cancer biology, such as through identifying and sequencing neoantigens, which are proteins that forms on cancer cells and can be a ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...